Σύγκριση μεθόδων

	Μοντέλο Emax: Φαρμακοδυναμική Ανάλυση Δόσης-Απόκρισης	Φαρμακοκινητικό Διαμερισματικό Μοντέλο
Πεδίο	Φαρμακομετρία	Φαρμακομετρία
Οικογένεια	Regression model	Regression model
Έτος προέλευσης	1981	1982
Δημιουργός	Holford & Sheiner	Gibaldi & Perrier
Τύπος	Nonlinear dose-response regression model	Deterministic ODE-based pharmacokinetic model
Θεμελιώδης πηγή	Holford, N. H. G., & Sheiner, L. B. (1981). Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clinical Pharmacokinetics, 6(6), 429–453.	Gibaldi, M., & Perrier, D. (1982). Pharmacokinetics (2nd ed.). Marcel Dekker. ISBN: 978-0-8247-1042-2
Εναλλακτικές ονομασίες	Maximum Effect Model, Hyperbolic Emax Model, Sigmoidal Emax Model, Emax Farmakodynamik Modeli	Mammillary Compartment Model, Multi-Compartment PK Model, Compartmental Analysis, Farmakokinetik Kompartman Modeli
Συναφείς	2	3
Σύνοψη	The Emax model is a nonlinear pharmacodynamic model that describes the relationship between drug concentration and biological effect. Introduced by Holford and Sheiner in 1981, it characterizes dose-response curves using three fundamental parameters: the maximum achievable effect (Emax), the concentration producing half-maximal effect (EC50), and an optional baseline effect (E0). It remains the standard framework in clinical pharmacology and drug development for quantifying pharmacodynamic dose-response relationships.	The pharmacokinetic compartment model represents the body as one or more hypothetical compartments interconnected by first-order rate processes, describing how a drug is absorbed, distributed, and eliminated over time. Systematized by Gibaldi and Perrier in 1982, these models use ordinary differential equations to characterize plasma concentration-time profiles. They are the cornerstone of drug development, dosage regimen design, and regulatory submission pharmacokinetic analyses.